awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35043675-0130D92B-84BC-4B8B-9749-EFC024C75D47
Q35043675-0130D92B-84BC-4B8B-9749-EFC024C75D47
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35043675-0130D92B-84BC-4B8B-9749-EFC024C75D47
Combination of EGFR-TKIs and chemotherapy as first-line therapy for advanced NSCLC: a meta-analysis.
P2860
Q35043675-0130D92B-84BC-4B8B-9749-EFC024C75D47
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35043675-0130D92B-84BC-4B8B-9749-EFC024C75D47
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bfd985636fbe474b3597e32096eac1c4d206d2c6
P2860
TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.